(September, 2025) President Donald Trump has signed a presidential memorandum ordering federal agencies, including the FDA, to tighten oversight of direct-to-consumer (DTC) prescription drug advertising. The move aims to ensure that drug companies are fully transparent and honest in how they market medicines to the public, especially on TV, social media and online platforms. Read more.